Journal article
Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway
Abstract
BackgroundCancer stem cells (CSCs) play an important role in cancer initiation, relapse and metastasis. To date, no specific medicine has been found to target CSCs as they are resistant to most conventional therapies and proliferate indefinitely. Compound Kushen Injection (CKI) has been widely used for cancer patients with remarkable therapeutic effects in Chinese clinical settings for many years. This study focused on whether CKI could inhibit …
Authors
Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z
Journal
Journal of Experimental & Clinical Cancer Research, Vol. 30, No. 1,
Publisher
Springer Nature
Publication Date
12 2011
DOI
10.1186/1756-9966-30-103
ISSN
0392-9078